SCHEMBL28260602

SCHEMBL28260602

Fc1ccn(Cc2ccccc2)n1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.49
RAB9A P51151 5/20 0.49
ALDH1A1 P00352 4/20 0.49
CYP19A1 P11511 4/20 0.48
CACNA1G O43497 5/20 0.47
CACNA1I Q9P0X4 5/20 0.47
L3MBTL1 Q9Y468 2/20 0.47
NFKB1 P19838 2/20 0.46
NFKB2 Q00653 2/20 0.46
RELA Q04206 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
LMNA P02545 3/20 0.45
KDM4E B2RXH2 2/20 0.45
HPGD P15428 2/20 0.45
MAPT P10636 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
CACNA1H O95180 4/20 0.42
HDAC1 Q13547 3/20 0.42
HDAC3 O15379 1/20 0.42
HDAC4 P56524 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27398369 0.78 CYP19A1 (0.50) NPC1RAB9AALDH1A1CYP19A1CACNA1G
SCHEMBL18577540 0.76 CYP19A1 (0.48) NPC1RAB9AALDH1A1CYP19A1CACNA1G
SCHEMBL8011610 0.76 CACNA1G (0.51) NPC1RAB9AALDH1A1CYP19A1CACNA1G
SCHEMBL22149669 0.76 CYP19A1 (0.48) NPC1RAB9AALDH1A1CYP19A1CACNA1G
SCHEMBL10247346 0.76 GFER (0.60) NPC1RAB9AALDH1A1CYP19A1CACNA1G
SCHEMBL18577609 0.76 CYP19A1 (0.48) NPC1RAB9AALDH1A1CYP19A1CACNA1G
SCHEMBL7862499 0.76 NPC1 (0.49) NPC1RAB9AALDH1A1CYP19A1CACNA1G
SCHEMBL634581 0.76 ALDH1A1 (0.65) NPC1RAB9AALDH1A1CYP19A1CACNA1G
SCHEMBL21070404 0.76 NPC1 (0.46) NPC1RAB9AALDH1A1CYP19A1CACNA1G
SCHEMBL17397357 0.76 CYP19A1 (0.44) NPC1RAB9AALDH1A1CYP19A1CACNA1G

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109071508-A Benzimidazole bis-indole compound as novel divalent IAP antagonist 南京明德新药研发股份有限公司 2018-12-21 CN disclosed